symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
SERA,1.86,0.27175,48360,58185450,0,1.1-4.25,-0.02,"Sera Prognostics, Inc.",USD,0001534969,US81749D1072,81749D107,NASDAQ Global Market,NASDAQ,Diagnostics & Research,https://seraprognostics.com,"Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.",Ms. Evguenia  Lindgardt M.B.A.,Healthcare,US,87,801 990 0520,2749 East Parleys Way,Salt Lake City,UT,84109,,0,https://financialmodelingprep.com/image-stock/SERA.png,2021-07-15,False,False,True,False,False
